Bloomage Biotechnology Corporation Limited (688363.SH): China Life Chengda plans to reduce its shareholding by no more than 2%
Huaxi Biology (688363.SH) announced that Guoshou Chengda plans to conduct centralized bidding and bulk transactions according to market conditions...
Bloomage Biotechnology Corporation Limited (688363.SH) announced that China Life Chengda plans to reduce its holdings of Huaxi Jinyu Bio-Technology through centralized bidding and bulk trading, with a total of up to 9.6336 million shares, representing no more than 2% of the company's total share capital, depending on market conditions.
 Related Articles 

SCHOLAR EDU (01769) and Shenzhen Huaxia Junyong have established a joint venture company to research and develop artificial intelligence for education, Siasun Robot&Automation.

Uber Technologies, Inc. (UBER.US)Q3 revenue surpasses expectations, Q4 adjusted core profit guidance slightly below expectations.

Zhejiang MTCN Technology (003026.SZ) shareholder LONGi Green Energy Technology and director Guo Bingjian plan to collectively reduce their shareholdings by no more than 3.66%.
SCHOLAR EDU (01769) and Shenzhen Huaxia Junyong have established a joint venture company to research and develop artificial intelligence for education, Siasun Robot&Automation.

Uber Technologies, Inc. (UBER.US)Q3 revenue surpasses expectations, Q4 adjusted core profit guidance slightly below expectations.

Zhejiang MTCN Technology (003026.SZ) shareholder LONGi Green Energy Technology and director Guo Bingjian plan to collectively reduce their shareholdings by no more than 3.66%.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


